Multifocal Contact Lenses for Presbyopia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to compare the experience of wearing multifocal contact lenses with using regular contact lenses and reading glasses. It focuses on assisting those with presbyopia, a common condition that makes close-up vision difficult with age. Individuals over 40 who need reading glasses for clear close-up vision may qualify for this study. The trial will evaluate the effectiveness and comfort of each option in everyday use. As an unphased study, it offers a unique opportunity to explore new ways to enhance vision and comfort.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but if you are using any medications that might affect the study results, you may not be eligible to participate.
What prior data suggests that these contact lenses are safe for presbyopia?
Research has shown that multifocal contact lenses are generally safe to use. Studies have found that they improve close-up vision while maintaining clear distance vision, without affecting contrast sensitivity. The FDA has approved these lenses for treating presbyopia, a condition involving difficulty focusing on nearby objects, and they are widely used.
Patient satisfaction scores exceed 90 out of 100 for both distance and middle-range vision, indicating that most users are pleased with the performance of multifocal lenses.
No major safety issues have been reported, making these lenses a well-tolerated choice for people with presbyopia.12345Why are researchers excited about this trial?
Researchers are excited about multifocal contact lenses for presbyopia because they offer a convenient, all-in-one solution for both distance and near vision. Unlike traditional spherical contact lenses that require additional reading glasses for close-up tasks, multifocal lenses integrate multiple prescriptions into one lens. This design mimics the eye's natural way of focusing, potentially providing a seamless transition between distances. By eliminating the need for reading glasses, multifocal lenses could enhance daily convenience and comfort for those with presbyopia.
What evidence suggests that this trial's treatments could be effective for presbyopia?
Research has shown that multifocal contact lenses, one of the treatments studied in this trial, can effectively improve vision for people with presbyopia, a condition that makes it difficult to see things up close. One study found that these lenses provide clear vision both near and far without affecting contrast sensitivity. Users report high satisfaction, with scores of about 96.2 out of 100 for distance vision and 85.0 out of 100 for near vision. Another study found that these lenses enhance vision at various distances while maintaining good overall visual quality. This trial compares multifocal contact lenses to spherical contact lenses used with reading glasses, offering a promising option for managing presbyopia without reading glasses.23678
Are You a Good Fit for This Trial?
This trial is for people at least 40 years old with presbyopia, who can see clearly at a distance with correction (20/25 vision), need extra magnification (+0.75D) for close work, and are in stable health without medication changes in the past month. It's not for those with eye diseases/infections, dry eye history, allergies to lens solutions or fluorescein, recent eye surgery, pregnancy/lactation plans during the study period.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants wear either multifocal contact lenses or spherical contact lenses with reading glasses to assess wear experience
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Multifocal contact lenses
- Spherical contact lenses
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University
Lead Sponsor